JPWO2020177818A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020177818A5
JPWO2020177818A5 JP2021547493A JP2021547493A JPWO2020177818A5 JP WO2020177818 A5 JPWO2020177818 A5 JP WO2020177818A5 JP 2021547493 A JP2021547493 A JP 2021547493A JP 2021547493 A JP2021547493 A JP 2021547493A JP WO2020177818 A5 JPWO2020177818 A5 JP WO2020177818A5
Authority
JP
Japan
Prior art keywords
chewing gum
gum composition
composition according
compressed chewing
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021547493A
Other languages
Japanese (ja)
Other versions
JP7531500B2 (en
JP2022521896A (en
Publication date
Priority claimed from US16/289,714 external-priority patent/US10933017B2/en
Priority claimed from CA3035409A external-priority patent/CA3035409C/en
Application filed filed Critical
Priority claimed from PCT/DK2019/050307 external-priority patent/WO2020177818A1/en
Publication of JP2022521896A publication Critical patent/JP2022521896A/en
Publication of JPWO2020177818A5 publication Critical patent/JPWO2020177818A5/ja
Application granted granted Critical
Publication of JP7531500B2 publication Critical patent/JP7531500B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (20)

カンナビノイドの経口投与のための打錠チューインガム組成物であって、
i)第1の粒子集団が、1種又は複数種のポリ酢酸ビニルエラストマー可塑剤を含む非水溶性ガムベースを含み、ガムベースポリマーは、5質量%未満のラウリン酸ビニル-酢酸ビニルコポリマーを含み、
ii)第2の粒子集団が水溶性チューインガム成分を含み、第2の粒子集団が非水溶性ガムベースを含まず、
複数種の粒子内に位置する水溶性チューインガム成分及びガムベースポリマーを含む非水溶性ガムベースを含み、
0.1~200mgの量で1種又は複数種のカンナビノイドを含む、打錠チューインガム組成物。
A compressed chewing gum composition for oral administration of cannabinoids comprising:
i) the first particle population comprises a water-insoluble gum base comprising one or more polyvinyl acetate elastomer plasticizers, the gum base polymer comprising less than 5% by weight of a vinyl laurate-vinyl acetate copolymer;
ii) the second population of particles comprises a water-soluble chewing gum ingredient and the second population of particles does not comprise a water-insoluble gum base;
a water-insoluble gum base comprising a plurality of water-soluble chewing gum ingredients located in particles and a gum base polymer ;
A compressed chewing gum composition comprising one or more cannabinoids in an amount of 0.1-200 mg .
1種又は複数種のポリ酢酸ビニルエラストマー可塑剤が、非水溶性ガムベースの8~50質量%の量で存在する、請求項1に記載の打錠チューインガム組成物。 2. A compressed chewing gum composition according to claim 1, wherein the one or more polyvinyl acetate elastomer plasticizers are present in an amount of 8-50% by weight of the water-insoluble gum base. 1種又は複数種のポリ酢酸ビニルエラストマー可塑剤が、非水溶性ガムベースの15~35質量%の量で存在する、請求項1又は2に記載の打錠チューインガム組成物。 A compressed chewing gum composition according to claim 1 or 2, wherein the one or more polyvinyl acetate elastomer plasticizers are present in an amount of 15-35% by weight of the water-insoluble gum base. 1種又は複数種のカンナビノイドの少なくとも10質量%が非結合型で存在する、請求項1から3のいずれか一項に記載の打錠チューインガム組成物。 4. A compressed chewing gum composition according to any one of claims 1 to 3, wherein at least 10% by weight of the cannabinoid(s) is present in unbound form. 第1の粒子集団が、打錠チューインガム組成物の15~95質量%の量で存在する、請求項1から4のいずれか一項に記載の打錠チューインガム組成物。 A compressed chewing gum composition according to any one of claims 1 to 4 , wherein the first particle population is present in an amount of 15-95% by weight of the compressed chewing gum composition. 第2の粒子集団が、打錠チューインガム組成物の40~80質量%の量で存在する、請求項1から5のいずれか一項に記載の打錠チューインガム組成物。 A compressed chewing gum composition according to any one of claims 1 to 5 , wherein the second population of particles is present in an amount of 40-80% by weight of the compressed chewing gum composition. 第1の粒子集団の非水溶性ガムベースの含有量が、第1の粒子集団の30質量%超である、請求項1から6のいずれか一項に記載の打錠チューインガム組成物。 7. A compressed chewing gum composition according to any one of claims 1 to 6 , wherein the water-insoluble gum base content of the first particle population is greater than 30% by weight of the first particle population. 第2の粒子集団の水溶性チューインガム成分の含有量が、第2の粒子集団の90質量%超である、請求項1から7のいずれか一項に記載の打錠チューインガム組成物。 8. The compressed chewing gum composition according to any one of claims 1 to 7 , wherein the content of water-soluble chewing gum ingredients in the second particle population is greater than 90% by mass of the second particle population. 非水溶性ガムベースが、チューインガム組成物の第1の層内に部分的に位置し、水溶性チューインガム成分が、チューインガム組成物の第2の層内に部分的に位置する、請求項1から8のいずれか一項に記載の打錠チューインガム組成物。 9. The composition of claims 1-8 , wherein the water-insoluble gum base is partially located within the first layer of the chewing gum composition and the water-soluble chewing gum component is partially located within the second layer of the chewing gum composition. A compressed chewing gum composition according to any one of the preceding claims. 第1の層の非水溶性ガムベースの含有量が、第1の層の30質量%超である、請求項1から9のいずれか一項に記載の打錠チューインガム組成物。 10. A compressed chewing gum composition according to any one of the preceding claims, wherein the content of water-insoluble gum base in the first layer is greater than 30% by weight of the first layer. 第1の層が第2の層に密着及び隣接している2つの層からなる、請求項1から10のいずれか一項に記載の打錠チューインガム組成物。 11. A compressed chewing gum composition according to any one of the preceding claims, wherein the first layer consists of two layers in close contact with and adjacent to the second layer. ガムベースが、ガムベースの10~40質量%の量の1種又は複数種の天然樹脂と、ガムベースの3~30質量%の量の1種又は複数種のエラストマーと、ガムベースの8~50質量%の量の1種又は複数種のポリ酢酸ビニルエラストマー可塑剤とを含む、請求項1から11のいずれか一項に記載の打錠チューインガム組成物。 The gum base comprises one or more natural resins in an amount of 10-40% by weight of the gum base, one or more elastomers in an amount of 3-30% by weight of the gum base, and 8-50% by weight of the gum base. 12. A compressed chewing gum composition according to any preceding claim, comprising an amount of one or more polyvinyl acetate elastomer plasticizers. チューインガム組成物中のガムベースの量が、打錠チューインガム組成物の15~60質量%である、請求項1から12のいずれか一項に記載の打錠チューインガム組成物。 A compressed chewing gum composition according to any one of claims 1 to 12 , wherein the amount of gum base in the chewing gum composition is from 15 to 60% by weight of the compressed chewing gum composition. 1種又は複数種のカンナビノイドの放出率が、経口投与から最初の5分以内で1種又は複数種のカンナビノイドの少なくとも20質量%である、請求項1から13のいずれか一項に記載の打錠チューインガム組成物。 14. A blow according to any one of claims 1 to 13 , wherein the release rate of the one or more cannabinoids is at least 20% by mass of the one or more cannabinoids within the first 5 minutes after oral administration. tablet chewing gum composition. 1種又は複数種のカンナビノイドが、カンナビジオール(CBD)、カンナビジオール酸(CBDA)、カンナビジバリン(CBDV)、その塩及び誘導体からなる群から選択された1種又は複数種のカンナビノイドを含む、請求項1から14のいずれか一項に記載の打錠チューインガム組成物。 wherein the one or more cannabinoids comprises one or more cannabinoids selected from the group consisting of cannabidiol (CBD), cannabidiolic acid (CBDA), cannabidivarin (CBDV), salts and derivatives thereof; 15. A compressed chewing gum composition according to any one of claims 1-14 . 1種又は複数種のカンナビノイドが、テトラヒドロカンナビノール(THC)、テトラヒドロカンナビノール酸(THCA)、テトラヒドロカンナビバリン(THCV)、その塩及び誘導体からなる群から選択された1種又は複数種のカンナビノイドを含む、請求項1から15のいずれか一項に記載の打錠チューインガム組成物。 The one or more cannabinoids are one or more cannabinoids selected from the group consisting of tetrahydrocannabinol (THC), tetrahydrocannabinolic acid (THCA), tetrahydrocannabivarin (THCV), salts and derivatives thereof. 16. A compressed chewing gum composition according to any one of claims 1 to 15 , comprising 1種又は複数種のカンナビノイドが、1種若しくは複数種の糖アルコール又は1種若しくは複数種の糖との予備混合物中に存在する、請求項1から16のいずれか一項に記載の打錠チューインガム組成物。 17. Compressed chewing gum according to any one of the preceding claims, wherein the one or more cannabinoids are present in a pre-mixture with one or more sugar alcohols or one or more sugars. Composition. チューインガムが、1種又は複数種のカンナビノイドのための脂質担体を含む、請求項1から17のいずれか一項に記載の打錠チューインガム組成物。 18. A compressed chewing gum composition according to any preceding claim, wherein the chewing gum comprises a lipid carrier for one or more cannabinoids. 疼痛、てんかん、がん、悪心、炎症、先天性障害、神経障害、経口感染、歯痛、睡眠時無呼吸、精神障害、胃腸障害、炎症性腸疾患、食欲喪失、糖尿病、線維筋痛症、及びそれらの組み合わせからなる群から選択された病状の治療又は緩和のための、請求項1から18のいずれか一項に記載のチューインガム組成物。 pain, epilepsy, cancer, nausea, inflammation, congenital disorders, neurological disorders, oral infections, toothache, sleep apnea, psychiatric disorders, gastrointestinal disorders, inflammatory bowel disease, loss of appetite, diabetes, fibromyalgia, and 19. A chewing gum composition according to any one of claims 1 to 18 for the treatment or alleviation of conditions selected from the group consisting of combinations thereof. 1種又は複数種のカンナビノイド及び酸素のバリアとして働く材料、好ましくはアクリロニトリル及びアクリル酸メチルのコポリマーを含む、請求項1から19のいずれか一項に記載の打錠チューインガム組成物を含むパッケージ。 20. A package containing a compressed chewing gum composition according to any one of the preceding claims, comprising one or more cannabinoids and a material acting as an oxygen barrier, preferably a copolymer of acrylonitrile and methyl acrylate.
JP2021547493A 2019-03-01 2019-10-10 Tableted cannabinoid chewing gum containing a polyvinyl acetate elastomer plasticizer Active JP7531500B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16/289,714 2019-03-01
US16/289,714 US10933017B2 (en) 2019-03-01 2019-03-01 Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
CA3035409A CA3035409C (en) 2019-03-01 2019-03-01 Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
CA3,035,409 2019-03-01
PCT/DK2019/050307 WO2020177818A1 (en) 2019-03-01 2019-10-10 Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers

Publications (3)

Publication Number Publication Date
JP2022521896A JP2022521896A (en) 2022-04-13
JPWO2020177818A5 true JPWO2020177818A5 (en) 2022-10-19
JP7531500B2 JP7531500B2 (en) 2024-08-09

Family

ID=68617968

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021547493A Active JP7531500B2 (en) 2019-03-01 2019-10-10 Tableted cannabinoid chewing gum containing a polyvinyl acetate elastomer plasticizer

Country Status (6)

Country Link
EP (1) EP3876916B1 (en)
JP (1) JP7531500B2 (en)
CN (1) CN113329743B (en)
AU (1) AU2019432305B2 (en)
DK (1) DK3876916T3 (en)
WO (1) WO2020177818A1 (en)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397580A (en) * 1993-10-22 1995-03-14 Wm. Wrigley Jr. Company Continuous gum base manufacture using sequential mixers
DE60217731T2 (en) * 2002-07-02 2007-10-18 Gumlink A/S COMPRESSED RESIN KABELET
US6986907B2 (en) 2003-07-28 2006-01-17 Wm. Wrigley Jr. Company Chewing gum base and chewing gum compositions
WO2009007769A1 (en) * 2007-07-06 2009-01-15 Gumlink A/S Multi-modular chewing gum tablet
EP2229157B1 (en) * 2007-12-20 2016-08-10 Fertin Pharma A/S Compressed chewing gum tablet
PT2280687T (en) 2008-03-26 2019-06-04 Stichting Sanammad Chewing gum compositions comprising cannabinoids
EP3359142B1 (en) * 2015-10-07 2020-12-09 NordicCan A/S Medical chewing gum comprising cannabinoid
US10842786B2 (en) * 2016-04-27 2020-11-24 Apirx Pharmaceutical Usa, Llc Chewing gum composition comprising cannabinoids and nicotine
US11529329B2 (en) * 2016-05-27 2022-12-20 Nordiccan A/S Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin
JP6908717B2 (en) * 2016-11-18 2021-07-28 フェルティン ファルマ アー/エス Oral delivery vehicle
CA3031530C (en) * 2019-01-25 2021-03-23 Medcan Pharma A/S Cannabinoid chewing gum with sugar alcohols

Similar Documents

Publication Publication Date Title
US11654111B2 (en) Oral solid cannabinoid formulations, methods for producing and using thereof
EP3448521B1 (en) Chewing gum composition comprising cannabinoids and nicotine
US11590230B2 (en) Compositions of therapeutic substances, methods and uses thereof
US11712430B2 (en) Formulated cannabis oil powder by nanoemulsification, methods of producing and uses thereof
WO2018165740A1 (en) Modified release multi-layer tablet cannabinoid formulations
WO2009082459A2 (en) Anti-aging composition containing resveratrol and method of administration
US20060189543A1 (en) Compositions and methods for the treatment of leukemia
Jayusman et al. Therapeutic potential of polyphenol and nanoparticles mediated delivery in periodontal inflammation: A review of current trends and future perspectives
US11717494B2 (en) Oral solid cannabinoid oil composition for treating gastrointestinal disorders
CN104379138B (en) Acamprosate formulations, methods of use thereof, and combinations comprising acamprosate formulations
WO2006097660A2 (en) Use of an onion extract for making a composition to control weight gain
JPWO2020177818A5 (en)
CN106822097A (en) A kind of pharmaceutical composition containing orlistat for losing weight
JPWO2020177819A5 (en)
JPWO2020035850A5 (en)
EP4058002A1 (en) Chewing gum containing synergistic medicinal compounds
JP2022553653A (en) Controlled release formulation of highly lipophilic physiologically active substance
WO2007103528A2 (en) Compressible resilient granules and formulations prepared therefrom
CN113423279A (en) Tabletted cannabinoid chewing gum with layered structure
CN109432082B (en) Pharmaceutical composition for preventing and treating chemical liver injury
EP4119124A1 (en) Microemulsion containing orally disintegrating film compositions with adjustable physical and rheological properties
US20240139100A1 (en) Transmucosal delivery of tocotrienols
CN113329743B (en) Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizer
JPWO2020151791A5 (en)
WO2022148672A1 (en) Oral solid cannabinoid oil composition for treating central nervous system disorders